Wapnick Pamela bought MGX
April 1, 2026 · Form 4 insider transaction
Wapnick Pamela bought 144,000 shares of Metagenomi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
144,000
Price
$0.00
Total value
N/A
InsiderWapnick Pamela
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after144,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.